Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Vaginal Mesh Lawsuit Lawyers at Wright & Schulte LLC Update Status of C.R. Bard Avaulta Transvaginal Mesh Lawsuit Litigation Following Mistrial
  • USA - English


News provided by

Wright & Schulte LLC

Jul 25, 2013, 00:10 ET

Share this article

Share toX

Share this article

Share toX

Wright & Schulte LLC offers free lawsuit evaluations to victims of transvaginal mesh injuries following implantation of vaginal mesh. Visit www.yourlegalhelp.com, or call toll-FREE 1-800-399-0795
Wright & Schulte LLC offers free lawsuit evaluations to victims of transvaginal mesh injuries following implantation of vaginal mesh. Visit www.yourlegalhelp.com, or call toll-FREE 1-800-399-0795

Columbus, OH (PRWEB) July 25, 2013 -- The Vaginal Mesh bellwether trial in a federal consolidated Transvaginal Mesh lawsuit was expected to weigh heavily on the fate of the remaining thousands of vaginal mesh lawsuits or bladder mesh lawsuits waiting for their day in court in which the Avaulta device is accused of causing serious and life-altering injuries. (In re C.R. Bard Inc. Pelvic Repair System Products Liability Litigation, MDL No. 2187)

Wright & Schulte LLC offers free lawsuit evaluations to victims of transvaginal mesh injuries following implantation of vaginal mesh. Visit www.yourlegalhelp.com, or call toll-FREE 1-800-399-0795

Post this

The trial was halted after a gynecological expert called during the second day of proceedings testified that the Avaulta vaginal mesh device had been removed from the market. This testimony went against pre-trial rulings that barred the admission of evidence regarding the device’s removal from the market. Fearing this testimony would unfairly bias a jury, U.S. District Judge Joseph Goodwin declared a mistrial, according to court documents report. (Cisson v. C.R. Bard Inc., 2:11-cv- 00195)

Wright & Schulte LLC is already representing numerous women who have allegedly experienced painful vaginal mesh complications due to products manufactured by C.R. Bard and other companies. If you or someone you love suffered serious and disabling transvaginal mesh complications following implantation of pelvic mesh to treat pelvic organ prolapse or stress urinary incontinence, please visit yourlegalhelp.com, or call toll-FREE 1-800-399-0795 to learn more about your options for legal recourse.

Though disappointing, thousands of C.R. Bard vaginal mesh lawsuits that remain to be tried in the C.R. litigation will put forth evidence to suggest that the company falsely represented the safety of Avaulta and that this vaginal mesh device is just one of many that caused women to suffer serious injuries

According to an Order issued by the Court on May 2, 2013 plaintiffs in Bard’s Avaulta vaginal mesh lawsuits will be permitted to enter evidence that shows company executives were OK with using a plastic resin material that the maker deemed was unfit for human implantation. Emails between company executives that where disclosed ahead of the first bellwether trial showed that Bard wanted to keep its plans for the plastics they were purchasing secret from the manufacturer, according to a Bloomberg report published on June 26th that detailed the discussion that led to the admission of this evidence. (bloomberg.com/news/2013-06-26/bard-used-mesh-plastic-found-unfit-for-humans-by-supplier.html)

The court documents contend, the Multidistrict Litigation in which Goodwin is presiding over contains more than 3,400 lawsuits filed against C.R. Bard, alone. Court documents further indicate that Goodwin is also presiding over other consolidated lawsuits against makers of vaginal mesh devices, more than 20,000 complaints in all.

According to the June 26th Bloomberg report, vaginal mesh devices like Bard’s Avaulta werebrought to the market through the Food and Drug Administration’s controversial “fast-track” approval system. This system grants clearance for medical devices which the manufacturer shows to be similar in design to previously-approved devices without conducting detailed safety testing first

The FDA approved a myriad of styles of vaginal mesh devices like Bard’s Avaulta in the treatment of stress urinary incontinence and pelvic organ prolapse. These conditions affect millions of women in the U.S. and that means many of them have been posed with the prospect of having a vaginal mesh device implanted, Bloomberg said.

After receiving thousands of reports of injuries linked to vaginal mesh devices like Bard’s Avaulta, the FDA issued a public notice in July 2011 which stated that injuries caused by vaginal mesh devices were “not rare” and that they may not provide any health benefits to women receiving them. [fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm262435.htm]

Since the FDA notice, thousands of women have filed transvaginal mesh lawsuits in separate multidistrict litigations established in the Southern District of West Virginia, including:

    In re: American Medical Systems, Inc., Pelvic Repair Systems Products Liability Litigation
    (MDL No. 2325)

    In re: Boston Scientific Corp., Pelvic Repair System Products Liability Litigation
    (MDL No. 2326);

    In re: Ethicon, Inc., Pelvic Repair System Products Liability Litigation (MDL No. 2327); and
    In Re: Coloplast Corp. Pelvic Support System Products Liability Litigation (MDL No. 2387)

About Wright & Schulte LLC
Wright & Schulte LLC, a defective medical device law firm, is dedicated to the belief that America’s legal system should work for the people. Every day, the attorneys of Wright & Schulte LLC stand up for the rights of people who have been injured or wronged by defective drugs and their side effects, complications from defective medical devices, and unsafe consumer products, and fight tirelessly to ensure that even the world’s most powerful corporations take responsibility for their actions. If you’re looking for a law firm that will guarantee the aggressive and personal representation you deserve, please do not hesitate to contact Wright & Schulte LLC today. Free case evaluations are available through yourlegalhelp.com, or call 1-800-399-0795.

Contact:
Wright & Schulte LLC
812 East National Road
Vandalia, Ohio 45377
1-800-399-0795
.

Richard Schulte, Wright & Schulte LLC, http://www.yourlegalhelp.com, 1-800-399-0795, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.